Financial Summary (All financials)
In millions, except per share items | May-31-21 | May-31-20 | May-31-19 | May-31-18 | May-31-17 | May-31-16 | May-31-15 | May-31-14 |
Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Selling, general and administrative | | | | | 2.0 | | 2.6 | 2.6 |
General and administrative | 3.5 | 3.2 | 2.7 | 2.1 | 0.7 | 0.6 | 0.7 | 0.6 |
EBIT | -23.4 | -16.0 | -10.8 | -9.4 | -6.8 | -7.3 | -10.5 | -13.2 |
Pre-tax income | -23.1 | -16.2 | -10.9 | -9.3 | -6.7 | -7.4 | -10.6 | -11.7 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Net income | -23.1 | -16.2 | -10.9 | -9.3 | -6.7 | -7.4 | -10.6 | -11.7 |
|
Diluted EPS | ($0.18) | ($0.14) | ($0.10) | ($0.09) | ($0.07) | ($0.09) | ($0.14) | ($0.17) |
Shares outstanding (diluted) | 125.7 | 119.7 | 108.6 | 101.3 | 92.0 | 84.5 | 75.5 | 67.9 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|